Tag: source

FORT WASHINGTON, Pa., July 02, 2025 (GLOBE NEWSWIRE) -- Coventry, the leader and creator of the secondary market for life insurance, today released the following statement:

Cheyenne, Wyoming, USA, July 02, 2025 (GLOBE NEWSWIRE) -- AxonDAO, a decentralized science (DeSci) organization building open-source infrastructure for ethical AI and scientific discovery, has awarded a strategic grant to Ranger, a platform that pays users to upload photos used in real-world research. The collaboration supports AxonDAO’s mission to empower individuals to contribute to science while retaining ownership and value from their data.

At the initiative and by the decision of the Board of AUGA group, RAB (code 126264360, address Konstitucijos ave. 21C, Vilnius, the “Company”), it has been decided to revoke the extraordinary General Meeting of Shareholders convened on July 14, 2025, following the decision of the Vilnius Regional Court to extend the deadline for submitting the Company's restructuring plan for Court approval until August 19, 2025. This Court decision was based on unresolved issues regarding the contested creditor claims in the Company's restructuring case, which currently prevent the creditors from making decisions in accordance with the Law on Legal Entities' Insolvency (hereinafter referred to as the "Insolvency Law").

AUGA group, RAB, kodas 126264360, adresas Konstitucijos pr. 21C, Vilnius (toliau –  Bendrovė) valdybos iniciatyva ir sprendimu buvo nuspręsta atšaukti 2025 m. liepos 14 d. sušauktą visuotinį neeilinį akcininkų susirinkimą, kadangi Vilniaus apygardos teismas neskundžiama nutartimi pratęsė Bendrovės restruktūrizavimo plano pateikimui teismui tvirtinti terminą iki 2025 m. rugpjūčio 19 d., remiantis tuo, kad dar nėra išspręsti klausimai dėl administratoriaus ginčijamų kreditorinių reikalavimų tvirtinimo Bendrovės restruktūrizavimo byloje ir dėl susidariusios situacijos Bendrovės kreditoriai šiuo metu negali priimti sprendimų Bendrovės restruktūrizavimo byloje Juridinių asmenų nemokumo įstatyme (toliau – Nemokumo įstatymas) numatyta tvarka.

"Insights into MENA's Clinical Trial Markets: Providing a Focused Analysis of Emerging Opportunities, Challenges, and Market Dynamics from 2024 to 2029"

Dubai, July 2, 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON”), announces today that it has completed the pricing of a private placement of USD 200 million of senior unsecured notes due in 2029 with institutional investors (the “Notes”), following its announcement on June 16, 2025 that it is considering options to raise external financing through a private placement.